BCS Wealth Management Sells 12,818 Shares of Colgate-Palmolive Company $CL

BCS Wealth Management lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 50.0% in the 1st quarter, Holdings Channel reports. The institutional investor owned 12,818 shares of the company’s stock after selling 12,818 shares during the quarter. BCS Wealth Management’s holdings in Colgate-Palmolive were worth $1,093,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the business. Kemnay Advisory Services Inc. bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $25,000. CBIZ Investment Advisory Services LLC boosted its holdings in Colgate-Palmolive by 86.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after acquiring an additional 150 shares during the period. TD Capital Management LLC grew its position in Colgate-Palmolive by 61.4% in the 4th quarter. TD Capital Management LLC now owns 326 shares of the company’s stock valued at $26,000 after acquiring an additional 124 shares during the last quarter. Triumph Capital Management grew its position in Colgate-Palmolive by 62.9% in the 4th quarter. Triumph Capital Management now owns 329 shares of the company’s stock valued at $26,000 after acquiring an additional 127 shares during the last quarter. Finally, Jessup Wealth Management Inc purchased a new stake in Colgate-Palmolive in the fourth quarter worth $26,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 3.4%

Shares of Colgate-Palmolive stock opened at $91.65 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The firm has a market capitalization of $73.34 billion, a price-to-earnings ratio of 35.66, a PEG ratio of 4.67 and a beta of 0.33. The firm’s 50 day simple moving average is $87.60 and its two-hundred day simple moving average is $86.82.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.94 by $0.03. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.91 earnings per share. Analysts predict that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be paid a $0.53 dividend. The ex-dividend date is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is 82.49%.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. UBS Group lifted their target price on Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 8th. Sanford C. Bernstein started coverage on shares of Colgate-Palmolive in a research note on Thursday, June 11th. They issued a “market perform” rating and a $96.00 price objective for the company. TD Cowen reiterated a “hold” rating and issued a $85.00 target price on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Finally, Royal Bank Of Canada reissued an “outperform” rating and issued a $102.00 price objective on shares of Colgate-Palmolive in a research report on Monday, May 4th. Twelve analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.